Scolaris Content Display Scolaris Content Display

Tratamiento quirúrgico para la enfermedad tubárica en mujeres a las que se les realizará fertilización in vitro

This is not the most recent version

Collapse all Expand all

References

References to studies included in this review

Dechaud 1998 {published data only}

Dechaud H, Daures JP, Amal F, Humeau C, Hedon B. Does previous salpingectomy improve implantation and pregnancy rates in patients with severe tubal factor infertility who are undergoing in vitro fertilization? A pilot prospective randomized study. Fertility & Sterility 1998;69:1020‐5.
Dechaud H, Daures JP, Arnal F, Humeau C, Hedon B. Salpingectomy before undergoing IVF can increase implantation rates in severe tubal infertility patients: a prospective randomised study. Human Reproduction Abstracts of 13th Annual Meeting of the ESHRE. 1997; Vol. 12:23‐4.

Hammadieh 2008 {published data only}

Hammadieh N, Afnan M, Sharif K, Evans J, Amso N. The effect of hydrosalpinx on IVF outcome: a prospective randomised controlled trial of vaginal ultrasound‐guided hydrosalpinx aspiration during egg collection. Fertility & Sterility2003; Vol. 80 (Suppl. 3):S131‐132.
Hammadieh N, Coomarasamy A, Bolarinde O, Papaioannou S, Afnan M, Sharif K. Ultrasound‐guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial. Human Reproduction 2008;23:1113‐7.

Kontoravdis 2006 {published data only}

Kontoravdis A, Makrakis E, Pantos K, Botsis D, Deligeoroglu E, Creatsas G. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertility and Sterility December 2006;Vol 86:1642‐8.

Moshin 2006 {published data only}

Moshin V, Hotineanu A. Reproductive outcome of the proximal tubal occlusion prior to IVF in patients with hydrosalpinx. Human reproduction. June 2006; Vol. 21:i193‐i194.

Strandell 1999 {published data only}

Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospective randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Human Reproduction 1999;14(11):2762‐9.
Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: cumulative results after salpingectomy in a randomised controlled trial. Human Reproduction 2001;16:2403‐10.

References to studies excluded from this review

Gelbaya 2006 {published data only}

Gelbaya TA, Nardo LG, Fitzgerald CT, Horne G, Brison DR, Lieberman BA. Ovarian response to gonadotrophins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges. Fertility and Sterility 2006;85(5):1464‐8.

Goldstein 1998 {published data only}

Goldstein DB, Sasaran LH, Stadtmauer L, Popa R. Selective salpingostomy‐salpingectomy (SSS) and medical treatment prior to IVF in patients with hydrosalpinx. Fertility & Sterility 1998;70(1):S320.

Hotineanu 2007 {published data only}

Hotineanu 2007  Hotineanu AL, Moshin VN, Hotineanu AV, Croitor ME. The effect of proximal tubal ''clamping'' prior to the IVF in patients with distal tubal occlusion. Human Reproduction July 2007;22(Supplement 1; Abstracts of the 23rd Annual Meeting of the European Society of Human Reproduction and Embryology):i126.

Mardesic 1999 {published data only}

Mardesic T, Muller P, Huttelová R, Zvárová J, Hulvert J, Voboril J, et al. Effect of salpingectomy on the results of IVF in women with tubal sterility‐‐prospective study. Ceska Gynekol. 2001;66(1):259‐64.
Mardesic T, Muller P, Voboril J, Hulvert J, Huttelova R, Becvarova V, et al. The influence of salpingectomy of hydrosalpinges visible on ultrasound on IVF results. A pilot prospective randomized study. Abstracts of 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics. Sydney, Australia, 9‐14 May, 1999:156.

Zolghadri 2006 {published data only}

Zolghadri J, Momtahan M, Alborzi S, Mohammadinejad A, Khosravi D. Pregnancy outcome in patients with early recurrent abortion following laparoscopic tubal corneal interruption of a fallopian tube with hydrosalpinx.. Fertility and Sterility July 2006;86(6):149‐51.

References to studies awaiting assessment

Hammadieh2008 {published data only}

Hammadieh N, Coomarasamy A, Ola B, Papaioannou S, Afnan M, Sharif K. Ultrasound‐guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial. Human reproduction 2008;23(5):1113‐7.

Mol 2008 {published data only}

Mol F, Strandell A, Jurkovic D, Yalcinkaya T, Verhoeve HR, et al. The ESEP study: salpingostomy versus salpingectomy for tubal ectopic pregnancy; the impact on future fertility: a randomised controlled trial. BMC women's health 2008;8:11.

Darwish 2005,2006, 2007 {published data only}

Darwish A, El Saman E. Hysteroscopic vs laparoscopic tubal occlusion of hydrosalpinges prior to IVF/ICSI. Human Reproduction 2006;21:i134.
Darwish A, ElSaman E. Hysteroscopic versus laparoscopic tubal occlusion of hydrosalpinges prior to IVF/ICSI. Middle‐East Fertility Society Journal 2005;10(Supplement 12th Annual Meeting of the Middle East Fertility Society 23‐26November):i126.
Darwish AM, El Saman AM. Is there a role for hysteroscopic tubal occlusion of functionless hydrosalpinges prior to IVF/IVCSI in modern practice?. Acta Obstetrica et Gynaecologica 2007;86:1484‐9.

Aboulghar 1990

Aboulghar MA, Mansour RT, Serour GI, Sattar MA, Awad MM, Amin Y. Transvaginal ultrasonic needle guided aspiration of pelvic inflammatory masses before ovulation induction for in vitro fertilization. Fertility & Sterility 1990;53:311.

Akman 1996

Akman MA, Garcia JE, Damewood MD, Watts LD, Katz E. Hydrosalpinx affects the implantation of previously cryopreserved embryos. Human Reproduction 1996;11:1013‐4.

Andersen 1994

Andersen A, Yue Z, Meng F, Petersen K. Low implantation rate after in‐vitro fertilisation in patients with hydrosalpinges diagnosed by ultrasonography. Human Reproduction 1994;9:1935‐8.

Andersen 1996

Andersen AN, Lindhard A, Loft A, Ziebe S, Andersen CY. The infertile patient with hydrosalpinges: IVF with or without salpingectomy?. Human Reproduction 1996;11:2081‐4.

Bloechle 1997

Bloechle M, Schreiner Th, Lisse K. Recurrence of hydrosalpinges after transvaginal aspiration of tubal fluid in an IVF cycle with development of a serometra. Human Reproduction 1997;12:703‐5.

Camus 1999

Camus E, Poncelet C, Goffinet F, Wainer B, Merlet F, Nisand I, et al. Pregnancy rates after in‐vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta‐analysis of published comparative studies. Human Reproduction May 1999;14(5):1243‐9.

Clarke 2008

JF Clarke, M van Rummste, C Farquhar, N Johnson, BW Mol, P Herbison. Measuring outcomes in fertility trials ‐ can we rely on clinical pregnancy rates?. Submitted for publication.

Csemiczky 1996

Csemiczky G, Landgren BM, Fried G, Wramsby H. High tubal damage grade is associated with low pregnancy rate in women undergoing in vitro fertilisation treatment. Human Reproduction 1996;11:2438‐40.

Dar 2000

Dar P, Sachs GS, Strassburger D, et al. Ovarian function before and after salpingectomy in artificial reproductive technology patients. Human Reproduction 2000;15:142‐4.

Dechaud 2004

Dechaud H, Reyftmann L, Faidherbe, Hamamah S, Hedon B. Evidence based reproductive surgery: tubal infertility. International congress series 2004;1266:96‐106.

Dias 2006

Dias S, McNamee R, Vail A. Evidence of improving quality of reporting of randomized controlled trial in subfertility. Human Reproduction 2006;21:2617‐27.

Dickens 1995

Dickens CJ, Maguiness SD, Comer MT, Palmer S, Rutherford AJ, Leese HJ. Human tubal fluid: formation and composition during vascular perfusion of the Fallopian tube. Human Reproduction 1995;10:505‐8.

Ducarme 2006

Ducarme G, Uzan M, Hugues JN, Cedrin‐Durnerin I, Ponselet C. Management of hydrosalpinx before or during in vitro fertilization ‐embryo transfer: a national postal survey in France. Fertility and Sterility 2006;86(4):1013‐16.

Englert 1987

Englert Y, Vekemans M, Lejeune B, Van Rysselberge M, Puissant F, Degueldre M, et al. Higher pregnancy rates after in vitro fertilization and embryo transfer in cases with sperm defects. Fertility & Sterility 1987;48:254‐7.

Evers 2002

Evers JL. Female subfertility. The Lancet 2002;360(9327):151‐9.

Eytan 2001

Eytan O, Azem F, Gull I, Wolman I, Elad D, Jaffa AJ. The mechanism of hydrosalpinx in embryo implantation. Human Reproduction 2001;12:2662‐7.

Fleming 1996

Fleming C, Hull MGR. Impaired implantation after in vitro fertilisation treatment associated with hydrosalpinx. British Journal of Obstetrics & Gynaecology 1996;103:268‐72.

Freeman 1996

Freeman MR, Whitworth CM, Hill GA. Hydrosalpinx reduces in vitro fertilisation / embryo transfer rates and in vitro blastocyst development. 52nd Annual Meeting of the American Fertility Society. 1996:S211.

Hammadieh 2004

Hammadieh N, Afnan M, Evans J, Sharif K, Amso N, Olufowobi O. A postal survey of hydrosalpinx management prior to IVF in the United Kingdom. Human Reproduction 2004;19(4):1009‐12.

Herman 1991

Herman A, Ron‐el R, Golan A, Soffer Y, Bukovsky Y, Caspi E. The dilemma of the optimal surgical procedure occurring in ectopic pregnancies in in‐vitro fertilisation. Human Reproduction 1991;6:1167‐9.

Higgins 2008

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version. 5.0.0. The Cochrane Collaboration, February 2008. Available from www.cochrane‐handbook.org.

Hsu 2005

Hsu CC, Yang TT, Hsu CT. Ovarian pregnancy resulting from cornual fistulae in a woman who had undergone bilateral salpingectomy. Fertility & Sterility 2005;83(1):205‐7.

Inovay 1999

Inovay J, Marton T, Urbancsek J, et al. Spontaneous bilateral cornual dehiscence early in the second trimester after bilateral laparoscopic salpingectomy and in vitro fertilization. Human Reproduction 1999;14:2471‐3.

Johnson 2002

Johnson NP, Merrilees M, Sadler L. IVF and tubal pathology ‐ not all bad news. Australian and New Zealand Journal of Obstetrics & Gynaecology 2002;42:285‐8.

Johnson2002

Johnson NP, Norris J. An Australasian survey of the management of hydrosalpinges in women due to undergo in vitro fertilisation. The Australian and New Zealand Journal of Obstetrics and Gynaecology 2002;42(3):271‐6.

Katz 1996

Katz E, Akman MA, Damewood MD, Garcia JE. Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in vitro fertilisation. Fertility & Sterility 1996;66:122‐5.

Kerin 2005

Kerin J, Swann N, Scroggs S, Rosenfield R. Hysteroscopic placement of Essure micro‐inserts to obstruct hydrosalpinges followed by IVF and successful pregnancy outcomes. Australian and New Zealand Journal of Obstetrics and Gynaecology 2005;45(s(1)):A11.

La Combe 2003

LaCombe. Adnexal torsion in a patient with hydrosalpinx who underwent tubal occlusion before in vitro fertilization. Fertility & Sterility 2003;79(2):437‐8.

Lass 1998

Lass A, Ellenbogen A, Croucher C, et al. Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization‐embryo transfer program. Fertility & Sterility 1998;70:1035‐8.

Mansour 1991

Mansour RT, Aboulghar MA, Serrour GI, Riad R. Fluid accumulation of the uterine cavity before embryo transfer: a possible hindrance for implantation. Journal of In vitro fertilisation and Embryo Transfer 1991;8:157‐9.

Meyer 1997

Meyer WR, Castelbaum AJ, Somkuti S, Sagoskin AW, Doyle M, Harris JE, et al. Hydrosalpinges adversely affect markers of endometrial receptivity. Human Reproduction 1997;12:1393‐8.

Mukherjee 1996

Mukhurjee T, Copperman AB, McCaffrey C. Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy. Fertility & Sterility 1996;66:851‐3.

Murray 1998

Murray DL, Sagoskin AW, Widra EA, Levy MJ. The adverse effect of hydrosalpinges on in vitro fertilisation pregnancy rates and the benefit of surgical correction. Fertility & Sterility 1998;69(1):619‐26.

Poe‐Ziegler 1995

Poe‐Ziegler R, Shelton KE, Toner JP. Salpingectomy(ies) improves the pregnancy rate after IVF in patients with unilateral or bilateral hydrosalpinx. Journal of Assisted Reproduction & Genetics 1995;12:S65.

Puttemans 1996

Puttemans PJ, Brosens IA. Salpingectomy improves in vitro fertilisation outcome in patients with a hydrosalpinx: blind victimisation of the fallopian tube?. Human Reproduction 1996;11:2079‐81.

Rosenfield 2005

Rosenfield RB, Stones RE, Coates A, Matteri RK, Hesla JS. Proximal occlusion of hydrosalpinx by hysteroscopic placement of microinsert before in vitro fertilization embryo transfer. Fertility & Sterility 2005;83(5):1547.

Russel 1991

Russel JB, Rodriguez Z, Komins JI. The use of transvaginal ultrasound to aspirate bilateral hydrosalpinges prior to in vitro fertilisation: a case report. Journal of In vitro fertilisation and Embryo Transfer 1991;8(4):213‐5.

Savic 1999

Savic B, Milacic D, Peako N. Hydrosalpingeal fluid aspiration during oocyte retrieval has beneficial effect on outcome of in‐vitro fertilization‐embryo transfer. Abstracts of the 15th Annual Meeting of the European Society of Human Reproduction and Embryology. 1999:310.

Shahara 1996

Shahara FI, Scott RT, Marut EL, Queenan JT. In‐vitro fertilisation outcome in women with hydrosalpinx. Human Reproduction 1996;11:526‐30.

Sharara 1999

Sharara FI. The role of hydrosalpinx in IVF: simply mechanical?. Human Reproduction 1999;14:577‐8.

Shariff 1994

Shariff K, Kaufmann S, Sharma V. Heterotopic pregnancy obtained after In‐vitro fertilization and embryo transfer following bilateral total salpingectomy: case report. Human Reproduction 1994;9:1966‐7.

Shelton 1996

Shelton KE, Butier L, Toner JP. Salpingectomy improves the pregnancy rate in in vitro fertilisation patients with hydrosalpinx. Human Reproduction 1996;11:523‐5.

Sowter 1997

Sowter MC, Akande VA, Williams JA, Hull MG. Is the outcome of in‐vitro fertilisation and embryo transfer treatment improved by spontaneous or surgical drainage of a hydrosalpinx?. Human Reproduction 1997;12:2147‐50.

Stadtmauer 2000

Stadtmauer LA, Riehl RM, Toma SK, Talbert LM. Cauterization of hydrosalpinges before in vitro fertilization is an effective surgical treatment associated with improved pregnancy rates. American Journal of Obstetrics & Gynecology 2000;183:367‐71.

Steptoe 1978

Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978;2:366.

Strandell 1994

Strandell A, Waldenstrom U, Nilsson L, Hamberger L. Hydrosalpinx reduces in‐vitro fertilisation / embryo transfer pregnancy rates. Human Reproduction 1994;9:861‐3.

Strandell 2001

Strandell A, Lindhard A, Waldenstrom U, et al. Salpingectomy prior to IVF does not impair the ovarian response. Human Reproduction 2001;16:1135‐9.

Strandell 2002

Strandell A, Lindhard A. Why does hydrosalpinx reduce fertility; the importance of hydro salpingeal fluid. Human Reproduction 2002;17(5):1141‐5.

Surrey 2001

Surrey AS, Schoolcraft WB. Laparoscopic management of hydrosalpinges before in vitro fertilization embryo transfer: salpingectomy versus proximal tubal occlusion. Fertility & Sterility March 2001;75(3):612‐7.

Tay 1997

Tay JI, Rutherford AJ, Killick SR, Maguiness SD, Partridge RJ, Leese HJ. Human tubal fluid: production, nutrient composition and response to adrenergic agents. Human Reproduction 1998;70:492‐9.

Taylor 2001

Taylor RC, Berkowitz J, McComb PF. Role of laparoscopic salpingostomy in the treatment of hydrosalpinx. Fertility and Sterilty 2001;75:594‐600.

Van Voorhis 1998

Van Voorhis BJ, Sparks AET, Syrop CH, Stovall DW. Ultrasound‐guided aspiration of hydrosalpinges is associated with improved pregnancy and implantation rates after in‐vitro fertilization cycles. Human Reproduction 1998;13:736‐9.

Vandromme 1995

Vandromme J, Chasse E, Lejeune B, Van Rysselberge M, Delvigne A, Leroy F. Hydrosalpinges in in vitro fertilisation: an unfavourable prognostic feature. Human Reproduction 1995;10:576‐9.

Vasquez 1995

Vasquez G, Boeckx K, Brosens IA. Prospective study of tubal mucosal lesions and fertility in hydrosalpinges. Human Reproduction 1995;10:1075‐8.

Zeyneloglu 1998

Zeyneloglu HB, Arici A, Olive DL. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization ‐ embryo transfer. Fertility & Sterility 1998;70:492‐9.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Dechaud 1998

Methods

Randomised controlled trial.

Single‐centre, Department of Obstetrics and Gynaecology at a university hospital (Montpelier, France).
Patient sampling: not explained.

Inclusion criteria: women with severe tubal infertility, not suitable for tubal repair.
Exclusion criteria: age >40 years; additional causes of infertility; tubal pathology suitable for repair by tubal catheterization, laparoscopic surgery, or microsurgical techniques; tubal pathology so severe as to require bilateral salpingectomy; lack of patient consent for salpingectomy or randomisation.

60 women recruited, 60 randomised (30 to laparoscopic bilateral salpingectomy and adhesiolysis; 30 to laparoscopic adhesiolysis).
Number excluded not known.
No loss to follow up.
60 women analysed.

Follow‐up duration 1‐5 years. Follow‐up scheme: not specified.

Participants

Age </=40 years (range 27‐36).
Type (primary or secondary) of infertility: not stated.
Duration of infertility, mean months (SD): laparoscopic salpingectomy group 55.2 (33.3); laparoscopic adhesiolysis group 48.0 (25.4).
Investigative work‐up: baseline FSH, endocrine laboratory screening, semen analysis, post coital test, laparoscopy and confirmatory test of ovulation.
Other contributory causes: none
Previous treatment: no previous IVF.

Diagnosis of tubal pathology: by laparoscopy and(or) HSG; diagnostic criteria are specified.
Extent of tubal pathology: salpingitis isthmica nodosa or hydrosalpinx with a poor prognosis (disturbed with mucosal folds or irregular walls on HSG; proximal nodes or a thick walled hydrosalpinx). Distribution: unclear.

Characteristics of IVF treatment:
IVF protocol: a GnRH agonist protocol with hMG and hCG.
Number of IVF ovarian stimulation cycles per woman: not stated.
Mean oocytes retrieved per cycle (SD): 10.1 (5.0) in the salpingectomy group; 10.5 (6.0) in the laparoscopic adhesiolysis group. No ICSI. Fertilization rate: not stated. Mean number of embryos transferred (SD): 3.3 (1.2) in the salpingectomy group; 3.4 (1.2) in the laparoscopic adhesiolysis; up to 5 embryos were replaced in some cases.

Interventions

Laparoscopic bilateral salpingectomy and adhesiolysis VERSUS laparoscopic adhesiolysis.

Criteria for surgical treatment prior to IVF: a communicating non‐draining hydrosalpinx with salpingitis isthmica nodosa.
Mean interval from surgical intervention to IVF in months (SD): treatment group 10.1 (7.5); control group 9.5 (7.2).
Cointerventions: none stated.
Data on performer: not stated.

Outcomes

PRIMARY OUTCOMES
Ongoing pregnancy rate ‐ not defined; reported per transfer.
Pregnancy rate ‐ not defined; reported per transfer, per oocyte retrieval, per IVF cycle.
Cumulative pregnancy rates were presented also and obtained with the use of cumulative proportion test (the cumulative probability of becoming pregnant after each IVF attempt according to the number of patients, the number of pregnancies for each IVF attempt and the number of patients who discontinued IVF after each IVF attempt). The investigators hypothesized that the likelihood of becoming pregnant would have been equal for the patients who became pregnant after IVF and for those who discontinued IVF treatment.

SECONDARY OUTCOMES
Implantation rate ‐ not defined.
Proportion of IVF cycles resulting in embryo transfer.
Ectopic pregnancy and miscarriage rate ‐ not defined.

Notes

Subsequent publication of the cumulative results from this trial (Strandell 2001) were excluded from meta‐analysis (not intention to treat and too many protocol breached when intention to treat data was provided).

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

With sealed opaque envelopes.

Blinding?
All outcomes. Participants, outcome assessors, clinicians, statisticians

High risk

No blinding.

Incomplete outcome data addressed?
Intention to treat for primary outcome?

Low risk

Intention to treat analysis is unclear; but number randomised is same as number analysed.

Free of selective reporting?

Low risk

No suggestion of selective reporting.

Detection adequate?

Low risk

Sufficient length of follow‐up: 1‐5 years.

Source of funding stated?

Unclear risk

Presence or absence of funding is not reported.

Powercalculation performed?

High risk

A power calculation was performed but not adhered to as the number calculated (322 patients in each group) would not be achieved in the setting of the trial. When the trial was ceased and the exact reasons for cessation are unknown.

Loss to Follow‐up explained?

Low risk

No withdrawals or losses to follow‐up.

Hammadieh 2008

Methods

Randomised controlled trial.

Single centre, non academic, trial in the Assisted Conception Unit of Birmingham Women's Hospital, UK.
Patient sampling unclear.

Inclusion criteria: a uni‐ or bilateral hydrosalpinx diagnosed by ultrasound during ovarian stimulation in the IVF cycle or previous to the IVF cycle, or women with severe tubal pathology on the waiting list for salpingectomy for hydrosalpinges.
Exclusion criteria: other major fertility factors.

66 women recruited and randomised (32 to aspiration; 34 to no intervention). 1,154 exclusions prior to randomisation. No women withdrew or lost to follow up. 66 women were analysed.

Follow‐up duration up to 1 IVF cycle. Type of follow‐up: biochemical pregnancy 14 days post ET; if positive ultrasound examination is performed 6 weeks post transfer. After diagnosis of viable pregnancy patients are referred to their GP.

Participants

Age (years (SD)): aspiration group: 33.4±4.5 / no intervention group 33.9±4.7.
Type (primary/secondary) of subfertility: primary infertility 32/66 (aspiration group 41%, control group 56%).
Duration of infertility: not stated.
Previous investigative work‐up: not stated other than baseline FSH levels.
Contributary causes to infertility: exclusion criterion.
Previous treatments: no previous IVF treatment; not otherwise specified.

Diagnosis of tubal pathology: by ultrasound and by DLS or HSG in 7 patients.
Characteristics of tubal pathology: hydrosalpinges. 14 bilateral (8 in the aspiration group; 6 in the non intervention group).

Characteristics of IVF treatment:
Ovarian stimulation protocol: long antagonist protocol.
Single IVF ovarian stimulation cycle per woman.
Mean oocytes retrieved at IVF (SD) ‐ aspiration group 14.1 (7.1); non intervention group 12.4 (7.1).Proportion undergoing ICSI, 5% aspiration group; 7% non‐intervention group. Mean no. of fertilized oocytes in the aspiration group 9.2 (5.2); 7.0 (4.6) in the non‐aspiration group. Mean embryos transferred per cycles (SD) ‐ 2.3 (0.58) in the aspiration group; 2.1 (0.64) in the control group.

Interventions

Aspiration of hydrosalpinx or hydrosalpinges after collection of all eggs (covered with intravenous Augmentin followed by 3 days of oral Azithromycin antibiotic) VERSUS no aspiration.

Criteria for surgical treatment prior to IVF ‐ Ultrasound visible hydrosalpinges (uni‐ or bilateral) during ovarian stimulation phase of IVF treatment or severe tubal pathology.
Timing of intervention: All interventions administered just after oocyte aspiration of the IVF cycle studied.
Cointerventions: antibiotics were administered in the aspiration group.
Data on performer: not stated.

Outcomes

PRIMARY OUTCOMES
Biochemical (urinary HCG test 14 days after ET) and clinical (transvaginal ultrasound verified gestation sac) pregnancy per woman.

SECONDARY OUTCOMES
Ectopic pregnancy rate ‐ not defined; presumably per woman.
Miscarriage ‐ any pregnancy loss before 12 weeks.
Implantation rate ‐ number of gestational sacs on ultrasound divided by the number of embryos transferred.
Pelvic infection ‐ pelvic abdominal pain and pyrexia or positive culture of genital swabs
Recurrence rate of hydrosalpinges after aspiration.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

Randomisation by computer algorithm using a third party administrator just prior to oocyte retrieval procedure.

Blinding?
All outcomes. Participants, outcome assessors, clinicians, statisticians

High risk

Investigator nor the outcome assessor were blinded.

Incomplete outcome data addressed?
Intention to treat for primary outcome?

Low risk

'Intention to treat' analysis performed (as there were no drop‐outs or losses).

Free of selective reporting?

Low risk

No suggestion of selective reporting.

Detection adequate?

Low risk

Follow‐up duration up to 1 IVF cycle.

Source of funding stated?

Low risk

No source of funding reported.

Powercalculation performed?

High risk

Power calculation performed ‐ sample size 158 not attained owing to decrease in recruitment rate by virtue of patient preference for salpingectomy, recruitment was stopped on advice of the Data Monitoring Committee after 4 years.

Loss to Follow‐up explained?

Low risk

Yes, no loss to follow‐up occurred.

Kontoravdis 2006

Methods

Randomised Controlled Trial

Study in two centres: a academic centre: Aretaieon University Hospital; a non‐academic centre: the Centre for Human Reproduction, Genesis Clinic; both in Athens, Greece. Patients recruited prospectively; patient sampling consecutively.

Inclusion criteria: Women aged ≤41 with unilateral of bilateral hydrosalpinges; confirmed by HSG, suitability for IVF‐ICSI treatment, FSH on day 2/3 <12mIU/ml, no contraindications for laparoscopic surgery, no history of IVF attempts before recruitment, absence of other obvious pelvic pathology in females.
Exclusion criteria: Not specified.

115 patients were recruited and randomised (50 to proximal tubal occlusion; 50 to salpingectomy; 15 to non‐intervention). 112 patients underwent IVF and were analysed. 3 women withdrew from IVF; 3 women didn't respond to ovarian stimulation and in 4 women IVF did not result in embryo's. 

Follow‐up scheme: up to the first IVF cycle after tubal surgery. Type: ultrasound 4 weeks after ET.

Participants

Age (years (SD)): 31±4.5 vs 29.8±3.4 vs 3.4±5.3.
Type (primary or secondary) of subfertility: primary subfertility in 92% vs 84% vs 87% of the patients; duration not stated.
Previous investigation: included baseline FSH.
Contributary causes for infertility: other obvious pathology was reason for exclusion.
Previous treatments: no previous fertility treatment.

Diagnosis of tubal pathology was confirmed with HSG. 

Characteristics and distribution of tubal pathology: all patients had hydrosalpinges; bilateral in 70/115 patients (70% vs 54% vs 54%). 70/115 women (58% vs 64% vs 60%) had ultrasound visible hydrosalpinges. 

Characteristics of IVF treatment:
IVF protocol: a standard long antagonist protocol; ovarian stimulation; rec FSH; HCG; luteal phase support; ET on day 3. Doxycycline and prednisolon 6 days after oocyte retrieval.
Number of ovarian stimulation cycles per woman: one
Collected oocytes (mean±SD): 11.6±4.9 in the laparoscopic occlusion group; 12.1±5.0 in the salpingectomy group, 10.9±5.1 in the non‐intervention group. ICSI procedures: n=7(14.9%)in the laparoscopic occlusion group; n=6(12.5%) in the salpingectomy group, n=3(20%) in the non‐intervention group. Fertilized oocytes (mean±SD): 8.7±3.9 in the laparoscopic occlusion group; 8.53±4.0 in the salpingectomy group, 7.9±5.1 in the non‐intervention group. No of transferred embryo's: 118 in the laparoscopic occlusion group; 121 in the salpingectomy group, 36 in the non‐intervention group.
Embryo's per ET (mean±SD) 2.6±0.6 in the laparoscopic occlusion group; 2.6±0.6 in the salpingectomy group, 2.6±0.8in the non‐intervention group. Number of transfers with all embryo's grade 2.7 in the laparoscopic occlusion group; 5 in the salpingectomy group, 1 in the non‐intervention group.

Interventions

Uni‐ or bilateral laparoscopic tubal occlusion by bipolar diathermy at two separate sites on the isthmic segment of the tube VERSUS uni‐ or bilateral salpingectomy; with transection 1 to 1.5 cm from the cornual section VERSUS no intervention.

Criteria for surgery: unilateral of bilateral hydrosalpinges.
Timing of surgery: 2 to 3 months after tubal surgery prior to IVF; time interval between randomisation to IVF in the control group:unclear.
co‐interventions: none stated.
Data on performer: not stated.

Outcomes

PRIMARY OBJECTIVES
Ongoing pregnancy rate ‐ (pregnancy's beyond first trimester) per 100 ET.
Clinical pregnancy rate ‐ (gestational sacs on ultrasound with fetal pole, 4 weeks after ET) per 100 ET.
Ectopic pregnancy rate ‐ defined per 100 ET.
Miscarriage rate ‐ abortion of clinical pregnancies (ultrasonographically identified pregnancies) per 100 ET.

SECONDARY OBJECTIVES:
Subgroup analysis for bilateral hydrosalpinges and ultrasound visible hydrosalpinges.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

Randomisation by computer generated randomisation in blocks.

Blinding?
All outcomes. Participants, outcome assessors, clinicians, statisticians

High risk

The operator and the IVF performer were the same person in some cases.

Incomplete outcome data addressed?
Intention to treat for primary outcome?

High risk

112 women analysed of 115 randomised. Intention to treat analysis not explicitly stated.

Free of selective reporting?

Low risk

No suggestions of selective outcome reporting.

Detection adequate?

Low risk

adequate detection of stated outcomes.

Source of funding stated?

Low risk

correspondence stated that there was no source of funding.

Powercalculation performed?

Unclear risk

Power calculation is performed and calculated sample sizes were achieved. However, power calculations in this trial were made with very large anticipated differences (46% vs73% comparing salpingectomy to tubal occlusion and 46% vs 14% comparing surgery to no surgery) and not performed correctly. It is quite unlikely that these anticipated differences would be achieved; and therefore it may be questioned whether the made power calculation was adhered to.

Loss to Follow‐up explained?

Low risk

Withdrawal and losses to follow‐up were explained.

Moshin 2006

Methods

Randomised Controlled Trial.

Single academic centre, Center for Reproductive Health and Genetics, Chisinau, Moldova.
Patients were recruited prospectively and consecutively.

Inclusion criteria: women with hydrosalpinges.
Exclusion criteria: not specified.

204 patients recruited and randomised (66 women randomised to no surgical treatment; 60 women randomised to salpingectomy; 78 randomised to proximal tubal occlusion) 204 women analysed. loss to follow‐up/withdrawal: none.

Follow‐up duration: up to one IVF cycle.
Type of follow‐up: diagnosis of pregnancy by ultrasound examination 21 days and 35 days after ET.

Participants

Age: similar in all groups; range: 22‐35 years
Type (primary or secondary): about 65% of the patients in each group were primary infertile.

Duration of infertility: >2 years (mean months (SD): salpingectomy group: 46.2 (27.2); tubal occlusion group: 47.4 (28.5); non‐intervention group: 46.9 (27.8)).

Previous investigative work‐up: ovulatory cycles, hormonal tests, transvaginal ultrasound examination of the genitalia interna, male semen parameters.
Contributary causes to infertility: none.
Previous fertility treatment: no previous IVF treatment.

Diagnosis of tubal pathology: bilateral distal tubal occlusion diagnosed by HSG or ultrasound visible hydrosalpinges.
Characteristics and distribution of tubal pathology: bilateral hydrosalpinges.

IVF:
Ovarian stimulation in a long course GnRH analogue protocol (Decapeptyl or Dipherelin) with a fixed doses (225 IU daily) of recombinant FSH for stimulation, starting on day 3 of the cycle. Ovarian response was monitored by ultrasonography and serum E2 concentration. Ovulation was triggered with 10000 IU of HCG (Pregnyl) when the leading follicles reached 18‐20 mm. Oocyte retrieval was carried out 36 hours after HCG administration. Retrieved oocytes were evaluated and fertilized by conventional insemination. Embryos were transferred on day 3 after insemination. : Utrogestan 400 mg/day vaginal from the day of ovum pick‐up until 12 week of pregnancy. Results reported over one cycle.
Number of oocytes retrieved: 9.8±5.5 in the non‐intervention group / 10.4±6.0 in the salpingectomy group, 10.2±5.7 in the proximal occlusion group.
Proportion undergoing ICSI: not stated. Fertilized oocytes: 6.8±4.6 in the non‐intervention group, 7.0±4.7 in the salpingectomy group, 6.9±4.6 in the proximal occlusion group.
Mean number of preembryo's transferred: 3.5±1.3 in the non‐intervention group, 3.4±1.2 in the salpingectomy group, 3.4±1.3 in the proximal occlusion group.

Interventions

Salpingectomy VERSUS proximal tubal clamping of hydrosalpinges VERSUS No intervention .

Criterium for intervention: ultrasound visible hydrosalpinges.

Timing of intervention: minimally 2 months before IVF treatment. Timing to the IVF treatment cycle after randomisation in the control group: unclear.
Cointerventions: not reported.
Data on performer: not reported.

Outcomes

PRIMARY OUTCOMES:

Clinical pregnancy ‐ gestational sac on ultrasound.

Notes

As data extraction on the abstract was limited; queries were resolved by contacting the author.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

By opaque numbered envelopes

Blinding?
All outcomes. Participants, outcome assessors, clinicians, statisticians

Unclear risk

Not stated.

Incomplete outcome data addressed?
Intention to treat for primary outcome?

Low risk

Not stated in abstract; but number of patients randomised is the same as numbers of patients analysed, correspondence clarified there was no loss to follow‐up or withdrawal.

Free of selective reporting?

Low risk

no suggestions of selective reporting.

Detection adequate?

Low risk

yes, adequate follow‐up after IVF.

Source of funding stated?

Low risk

Source of funding: the Academy of Science of the Republic of Moldova (clarified by correspondence)

Powercalculation performed?

Unclear risk

Not clear. As study sizes were small it may be presumed that they have not been adhered to if they where performed.

Loss to Follow‐up explained?

Low risk

No loss to Follow‐up/ withdrawal, clarified by correspondence.

Strandell 1999

Methods

Randomised controlled trial.

Multicentre trial involving 9 Scandinavian IVF centres.
Patients recruited prospectively; patient sampling not explained explicitly.

Inclusion criteria: hydrosalpinges, laparoscopic acces ability, age<39 at time of randomisation.
Exclusion criteria ‐ previous IVF; uterine fibroids.Concomitant male factor requiring ICSI accepted if centre had established successful ICSI programme with results equivalent to conventional IVF.

204 women were recruited and randomised. Number of exclusions not known. 5 patients of the intervention group did not undergo surgery; 6 patients in the intervention group and 6 patients in the non‐intervention group did not undergo IVF. 204 women were analysed.
Follow‐up duration up to 1 IVF cycle (further follow‐up data anticipated).

Participants

Age <39 years (range 22‐38)
Type of infertility: majority primary infertility (treatment group 73%, control group 63%)
Duration of infertility not stated.
Investigative work‐up not stated.
Contributary causes to infertility: not stated.
Previous fertility treatment: not stated; no previous IVF.

Diagnosis of tubal pathology: by HSG or laparoscopy. 37(51%) had ultrasound visible hydrosalpinges compared to 42(57%).

Characteristics and distribution of tubal pathology: Hydrosalpinges. Bilateral in 69(59%) and 36(41%); unilateral in 47(41%) and 52(59%).

Characteristics of IVF treatment :
IVF protocol: Long GnRh antagonist protocol, with either HMG of FSH.
1‐2 IVF ovarian stimulation cycles per woman.
Mean oocytes retrieved at IVF (SD) ‐ 10.6 (5.9) in the salpingectomy group; 10.6 (6.1) in the non intervention group. Proportion undergoing ICSI, 13.1% in the salpingectomy group; in the non intervention group12.6%. Mean no. of fertilized and cleaved oocytes in treatment group 6.8 (4.8); 7.0 (4.9) in the non intervention group. Mean embryos transferred per cycles (SD) ‐ treatment group 2.0 (0.3); 2.0 (0.4)in the non intervention group.

Interventions

Laparoscopic bilateral or unilateral salpingectomy (or, if technical difficulties e.g. extensive adhesions, proximal ligation and distal fenestration recommended) VERSUS no surgery.

Criteria for surgical treatment prior to IVF ‐ Uni‐ or bilateral hydrosalpinges (a distally occluded pathologically dilated tube or one which became pathologically dilated on patency testing by HSG/laparoscopy.
Interval from surgical intervention to IVF ‐ minimum 2 months, IVF was performed in the control group directly after randomisation.
Co‐interventions: none (deviations from protocol though)
Data on surgeons: not stated.

Outcomes

PRIMARY OUTCOMES
Ongoing pregnancy (pregnancy>20 weeks) or delivery rate in first cycle per woman, per started cycle, and per transfer cycle.
Pregnancy rate ‐ per woman, per started cycle and per transfer cycle.
Clinical pregnancy verified by gestational sac on ultrasound.

SECONDARY OUTCOMES
Ectopic pregnancy rate ‐ per implanted embryo's/ clinical pregnancy
Miscarriage rate ‐ not defined, presumably as outcome of clinical pregnancy
Implantation rate ‐ number of gestational sacs on ultrasound divided by the number of embryos transferred.
Multiple pregnancy rate not stated

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

True randomisation ‐ sealed opaque envelopes in blocks of 10‐30.

Blinding?
All outcomes. Participants, outcome assessors, clinicians, statisticians

High risk

No blinding.

Incomplete outcome data addressed?
Intention to treat for primary outcome?

Low risk

'Intention to treat' analysis performed.

Free of selective reporting?

Low risk

No suggestions of selective reporting.

Detection adequate?

Low risk

Follow‐up duration up to 1 IVF cycle (further follow‐up data anticipated).

Source of funding stated?

Low risk

Study was funded by grants from the Goteborg Medical Society, the Hjalmar Svensson Foundation and the society 'ordensallskapet W:6'

Powercalculation performed?

High risk

Power calculation performed ‐ sample size 300 not adhered to due to decrease in recruitment rate.

Loss to Follow‐up explained?

Low risk

Withdrawal and loss to follow up explained.

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Gelbaya 2006

Retrospective non‐randomised controlled study.

Goldstein 1998

Study design and whether randomisation has been performed is unclear. It appears that patients serve as there own control after surgical intervention. Correspondance was sought to resolve this issue, but not with success.

Hotineanu 2007

This trial was excluded because this article compared proximal/distal tubal occlusion with clamping; however comparisons were between outcomes in different degrees of tubal pathology rather than different interventions. Comparative data was not obtained as correspondence was unsuccessful.

Mardesic 1999

This trial is not a randomised trial ‐ the 'control' group was historical (the same women prior to their salpingectomy) and biased by the fact that no pregnancies occurred.

Zolghadri 2006

The primary outcome of this study is the continuation of spontaneous pregnancy; IVF is not performed after tubal surgery.

Characteristics of ongoing studies [ordered by study ID]

Darwish 2005,2006, 2007

Trial name or title

Is there a role for hysteroscopic tubal occlusion of functionless hydrosalpinges prior to IVF/ICSI in modern practice?

Methods

Randomised controlled trial.

Single academic centre in Egypt (women's Health University  Center, Assiut University, Assiut Egypt)
Patient recruitment from April 2004 to October 2006.

Inclusion criteria: women with uni‐ or bilaterally laparoscopically‐proven functionless hydrosalpinges (a large blocked tube with lost major and minor folds) scheduled for IVF.
Exclusion criteria: women with a frozen pelvis at laparoscopy or inaccessible tubes at lap or hysteroscopy.

Follow‐up: HSG in the following cycle after the procedure; follow‐up procedure for pregnancy unclear.

Participants

Women with uni‐ or bilaterally laparoscopically‐proven functionless hydrosalpinges scheduled for IVF. Women with a frozen pelvis at laparoscopy or inaccessible tubes at lap or hysteroscopy were excluded.

Interventions

Laparoscopic occlusion by coagulation and incision of the isthmic part of the fallopian tube VERSUS Hysteroscopic tubal occlusion by electrocautery with a rollerball electrode (3mm) introduced by a resectoscope; after cervical priming with misoprostol 200mg. 
Procedures are performed under broad‐spectrum antibiotic coverage. 

Outcomes

PRIMARY OUTCOMES:
Feasible acces
Confirmed tubal occlusion

SECONDARY OUTCOMES
Operative time
Hospital stay
Complications
Pregnancy: not defined.

Starting date

April 2004

Contact information

Atef M.M. Darwish, dept of obstetrics and gynaecology, women's Health University, P.O. Box(1), 71111 Assiut Egypt. [email protected]

Notes

The objective of Darwish 2007 is mainly to conduct a safety study and a study to address the value of hysteroscopic tubal occlusion compared to laparoscopic tubal occlusion. This current study is stated to be only a preliminary study of which the follow‐up time was to short to detect pregnancy. Subsequent studies might report outcomes in terms of pregnancy.

Data and analyses

Open in table viewer
Comparison 1. Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Ongoing pregnancy rate Show forest plot

3

329

Odds Ratio (M‐H, Fixed, 95% CI)

2.20 [1.26, 3.82]

Analysis 1.1

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 1 Ongoing pregnancy rate.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 1 Ongoing pregnancy rate.

1.1 Laparoscopic bilateral salpingectomy and adhesiolysis versus no surgery on the fallopian tube

1

60

Odds Ratio (M‐H, Fixed, 95% CI)

3.06 [0.97, 9.66]

1.2 Laparoscopic salpingectomy versus no intervention

2

269

Odds Ratio (M‐H, Fixed, 95% CI)

1.99 [1.06, 3.74]

2 Clinical pregnancy rate Show forest plot

3

395

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.31 [1.48, 3.62]

Analysis 1.2

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 2 Clinical pregnancy rate.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 2 Clinical pregnancy rate.

2.1 Laparoscopic salpingectomy versus no intervention

3

395

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.31 [1.48, 3.62]

3 Pregnancy rate ‐ any definition Show forest plot

4

455

Odds Ratio (M‐H, Fixed, 95% CI)

2.49 [1.60, 3.86]

Analysis 1.3

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 3 Pregnancy rate ‐ any definition.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 3 Pregnancy rate ‐ any definition.

3.1 Laparoscopic bilateral salpingectomy and adhesiolysis versus no surgery on the fallopian tube

1

60

Odds Ratio (M‐H, Fixed, 95% CI)

3.06 [0.97, 9.66]

3.2 Laparoscopic salpingectomy versus no intervention

3

395

Odds Ratio (M‐H, Fixed, 95% CI)

2.40 [1.49, 3.86]

4 Ectopic pregnancy rate Show forest plot

3

329

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.68 [0.13, 3.56]

Analysis 1.4

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 4 Ectopic pregnancy rate.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 4 Ectopic pregnancy rate.

4.1 Laparoscopic bilateral salpingectomy and adhesiolysis versus laparoscopic adhesiolysis

1

60

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 6.82]

4.2 Laparoscopic salpingectomy versus no intervention

2

269

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.96 [0.15, 6.01]

5 Miscarriage rate Show forest plot

3

115

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.38 [0.11, 1.28]

Analysis 1.5

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 5 Miscarriage rate.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 5 Miscarriage rate.

5.1 Laparoscopic bilateral salpingectomy and adhesiolysis versus laparoscopic adhesiolysis

1

38

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.17 [0.01, 5.24]

5.2 Laparoscopic salpingectomy versus no intervention

2

77

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.42 [0.12, 1.57]

6 Surgical complication rate Show forest plot

1

204

Peto Odds Ratio (Peto, Fixed, 95% CI)

5.86 [0.35, 96.79]

Analysis 1.6

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 6 Surgical complication rate.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 6 Surgical complication rate.

6.1 Laparoscopic salpingectomy versus no intervention

1

204

Peto Odds Ratio (Peto, Fixed, 95% CI)

5.86 [0.35, 96.79]

Open in table viewer
Comparison 2. Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Ongoing pregnancy rate Show forest plot

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

7.21 [0.87, 59.57]

Analysis 2.1

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 1 Ongoing pregnancy rate.

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 1 Ongoing pregnancy rate.

1.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

7.21 [0.87, 59.57]

2 Clinical pregnancy rate Show forest plot

2

209

Odds Ratio (M‐H, Fixed, 95% CI)

4.66 [2.17, 10.01]

Analysis 2.2

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 2 Clinical pregnancy rate.

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 2 Clinical pregnancy rate.

2.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

4.33 [0.88, 21.30]

2.2 Proximal tubal clamping VERSUS no intervention

1

144

Odds Ratio (M‐H, Fixed, 95% CI)

4.78 [2.01, 11.38]

3 Pregnancy rate ‐ any definition Show forest plot

2

209

Odds Ratio (M‐H, Fixed, 95% CI)

4.66 [2.17, 10.01]

Analysis 2.3

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 3 Pregnancy rate ‐ any definition.

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 3 Pregnancy rate ‐ any definition.

3.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

4.33 [0.88, 21.30]

3.2 Laparoscopic proximal tubal clamping VERSUS no intervention

1

144

Odds Ratio (M‐H, Fixed, 95% CI)

4.78 [2.01, 11.38]

4 Ectopic pregnancy rate Show forest plot

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

0.94 [0.04, 24.25]

Analysis 2.4

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 4 Ectopic pregnancy rate.

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 4 Ectopic pregnancy rate.

4.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

0.94 [0.04, 24.25]

5 Miscarriage rate Show forest plot

1

25

Odds Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 3.09]

Analysis 2.5

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 5 Miscarriage rate.

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 5 Miscarriage rate.

5.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention

1

25

Odds Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 3.09]

Open in table viewer
Comparison 3. Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Clinical pregnancy rate Show forest plot

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

1.97 [0.62, 6.29]

Analysis 3.1

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 1 Clinical pregnancy rate.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 1 Clinical pregnancy rate.

1.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

1.97 [0.62, 6.29]

2 Biochemical pregnancy rate Show forest plot

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

2.78 [0.93, 8.27]

Analysis 3.2

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 2 Biochemical pregnancy rate.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 2 Biochemical pregnancy rate.

2.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

2.78 [0.93, 8.27]

3 Pregnancy rate ‐ any definition Show forest plot

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

1.97 [0.62, 6.29]

Analysis 3.3

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 3 Pregnancy rate ‐ any definition.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 3 Pregnancy rate ‐ any definition.

3.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

1.97 [0.62, 6.29]

4 Ectopic pregnancy rate Show forest plot

1

66

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 3.4

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 4 Ectopic pregnancy rate.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 4 Ectopic pregnancy rate.

4.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

66

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5 Miscarriage rate Show forest plot

1

16

Odds Ratio (M‐H, Fixed, 95% CI)

1.25 [0.09, 17.65]

Analysis 3.5

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 5 Miscarriage rate.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 5 Miscarriage rate.

5.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

16

Odds Ratio (M‐H, Fixed, 95% CI)

1.25 [0.09, 17.65]

6 Surgical complication rate Show forest plot

1

66

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 3.6

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 6 Surgical complication rate.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 6 Surgical complication rate.

6.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

66

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Open in table viewer
Comparison 4. Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Ongoing pregnancy rate Show forest plot

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.65 [0.74, 3.71]

Analysis 4.1

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 1 Ongoing pregnancy rate.

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 1 Ongoing pregnancy rate.

1.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.65 [0.74, 3.71]

2 Clinical pregnancy rate Show forest plot

2

238

Odds Ratio (M‐H, Fixed, 95% CI)

1.28 [0.76, 2.14]

Analysis 4.2

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 2 Clinical pregnancy rate.

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 2 Clinical pregnancy rate.

2.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.63 [0.74, 3.59]

2.2 Laparoscopic proximal tubal clamping VERSUS laparoscopic salpingectomy

1

138

Odds Ratio (M‐H, Fixed, 95% CI)

1.06 [0.53, 2.12]

3 Pregnancy rate ‐ any definition Show forest plot

2

238

Odds Ratio (M‐H, Fixed, 95% CI)

1.28 [0.76, 2.14]

Analysis 4.3

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 3 Pregnancy rate ‐ any definition.

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 3 Pregnancy rate ‐ any definition.

3.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.63 [0.74, 3.59]

3.2 Laparoscopic proximal tubal clamping VERSUS laparoscopic salpingectomy

1

138

Odds Ratio (M‐H, Fixed, 95% CI)

1.06 [0.53, 2.12]

4 Ectopic pregnancy rate Show forest plot

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

3.06 [0.12, 76.95]

Analysis 4.4

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 4 Ectopic pregnancy rate.

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 4 Ectopic pregnancy rate.

4.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

3.06 [0.12, 76.95]

5 Miscarriage rate Show forest plot

1

43

Odds Ratio (M‐H, Fixed, 95% CI)

1.35 [0.20, 9.02]

Analysis 4.5

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 5 Miscarriage rate.

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 5 Miscarriage rate.

5.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy

1

43

Odds Ratio (M‐H, Fixed, 95% CI)

1.35 [0.20, 9.02]

Open in table viewer
Comparison 5. Surgical treatment (all types) VERSUS no surgical treatment

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Salpingectomy (all methods) VERSUS no surgical treatment Show forest plot

4

Odds Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 5.1

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 1 Salpingectomy (all methods) VERSUS no surgical treatment.

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 1 Salpingectomy (all methods) VERSUS no surgical treatment.

1.1 Ongoing pregnancy rate

3

329

Odds Ratio (M‐H, Fixed, 95% CI)

2.20 [1.26, 3.82]

1.2 Clinical pregnancy rate

3

395

Odds Ratio (M‐H, Fixed, 95% CI)

2.40 [1.49, 3.86]

1.3 Pregnancy rate ‐ any definition

4

455

Odds Ratio (M‐H, Fixed, 95% CI)

2.49 [1.60, 3.86]

1.4 Ectopic pregnancy rate

3

329

Odds Ratio (M‐H, Fixed, 95% CI)

0.64 [0.15, 2.75]

1.5 Miscarriage rate

3

329

Odds Ratio (M‐H, Fixed, 95% CI)

0.86 [0.31, 2.38]

1.6 Surgical complication rate

1

204

Odds Ratio (M‐H, Fixed, 95% CI)

3.86 [0.18, 81.52]

2 Tubal occlusion (all methods) VERSUS no surgical treatment Show forest plot

2

Odds Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 5.2

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 2 Tubal occlusion (all methods) VERSUS no surgical treatment.

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 2 Tubal occlusion (all methods) VERSUS no surgical treatment.

2.1 Ongoing pregnancy rate

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

7.21 [0.87, 59.57]

2.2 Clinical pregnancy rate

2

209

Odds Ratio (M‐H, Fixed, 95% CI)

4.66 [2.17, 10.01]

2.3 Ectopic pregnancy rate

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

0.94 [0.04, 24.25]

2.4 Miscarriage rate

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

0.89 [0.09, 9.28]

3 Aspiration of hydro salpingeal fluid (all methods) VERSUS no surgical treatment Show forest plot

1

Odds Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 5.3

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 3 Aspiration of hydro salpingeal fluid (all methods) VERSUS no surgical treatment.

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 3 Aspiration of hydro salpingeal fluid (all methods) VERSUS no surgical treatment.

3.1 Clinical pregnancy rate

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

1.97 [0.62, 6.29]

3.2 Biochemical pregnancy rate

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

2.78 [0.93, 8.27]

3.3 Ectopic pregnancy rate

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.4 Miscarriage rate

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

2.07 [0.18, 24.01]

3.5 Surgical complication rate

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Open in table viewer
Comparison 6. Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Tubal occlusion (all methods) VERSUS Salpingectomy (all methods) Show forest plot

2

Odds Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 6.1

Comparison 6 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 1 Tubal occlusion (all methods) VERSUS Salpingectomy (all methods).

Comparison 6 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 1 Tubal occlusion (all methods) VERSUS Salpingectomy (all methods).

1.1 Ongoing pregnancy rate

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.65 [0.74, 3.71]

1.2 Clinical pregnancy rate

2

238

Odds Ratio (M‐H, Fixed, 95% CI)

1.28 [0.76, 2.14]

1.3 Ectopic pregnancy rate

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

0.33 [0.01, 8.21]

1.4 Miscarriage rate

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.53 [0.24, 9.59]

Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
Figures and Tables -
Figure 1

Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
Figures and Tables -
Figure 2

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

Forest plot of comparison: Surgical treatment (all types) VERSUS no surgical treatment: Salpingectomy (all methods) VERSUS no surgical treatment. Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Pregnancy rate according to any definition, Ectopic pregnancy rate, Miscarriage rate, Surgical complication rate.
Figures and Tables -
Figure 3

Forest plot of comparison: Surgical treatment (all types) VERSUS no surgical treatment: Salpingectomy (all methods) VERSUS no surgical treatment. Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Pregnancy rate according to any definition, Ectopic pregnancy rate, Miscarriage rate, Surgical complication rate.

Forest plot of comparison: Surgical treatment (all types) VERSUS no surgical treatment: Tubal occlusion (all methods) VERSUS no surgical treatment. Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Ectopic pregnancy rate, Miscarriage rate, Surgical complication rate.
Figures and Tables -
Figure 4

Forest plot of comparison: Surgical treatment (all types) VERSUS no surgical treatment: Tubal occlusion (all methods) VERSUS no surgical treatment. Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Ectopic pregnancy rate, Miscarriage rate, Surgical complication rate.

Forest plot of comparison: Surgical treatment (all types) VERSUS no surgical treatment: Aspiration of hydro salpingeal fluid (all methods) VERSUS no surgical treatment. Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Ectopic pregnancy rate, Miscarriage rate, Surgical complication rate.
Figures and Tables -
Figure 5

Forest plot of comparison: Surgical treatment (all types) VERSUS no surgical treatment: Aspiration of hydro salpingeal fluid (all methods) VERSUS no surgical treatment. Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Ectopic pregnancy rate, Miscarriage rate, Surgical complication rate.

Forest plot of comparison: Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube: Tubal occlusion (all methods) VERSUS Salpingectomy (all methods). Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Ectopic pregnancy rate, Miscarriage rate.
Figures and Tables -
Figure 6

Forest plot of comparison: Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube: Tubal occlusion (all methods) VERSUS Salpingectomy (all methods). Outcomes: Ongoing pregnancy rate, Clinical pregnancy rate, Ectopic pregnancy rate, Miscarriage rate.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 1 Ongoing pregnancy rate.
Figures and Tables -
Analysis 1.1

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 1 Ongoing pregnancy rate.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 2 Clinical pregnancy rate.
Figures and Tables -
Analysis 1.2

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 2 Clinical pregnancy rate.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 3 Pregnancy rate ‐ any definition.
Figures and Tables -
Analysis 1.3

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 3 Pregnancy rate ‐ any definition.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 4 Ectopic pregnancy rate.
Figures and Tables -
Analysis 1.4

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 4 Ectopic pregnancy rate.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 5 Miscarriage rate.
Figures and Tables -
Analysis 1.5

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 5 Miscarriage rate.

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 6 Surgical complication rate.
Figures and Tables -
Analysis 1.6

Comparison 1 Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types), Outcome 6 Surgical complication rate.

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 1 Ongoing pregnancy rate.
Figures and Tables -
Analysis 2.1

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 1 Ongoing pregnancy rate.

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 2 Clinical pregnancy rate.
Figures and Tables -
Analysis 2.2

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 2 Clinical pregnancy rate.

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 3 Pregnancy rate ‐ any definition.
Figures and Tables -
Analysis 2.3

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 3 Pregnancy rate ‐ any definition.

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 4 Ectopic pregnancy rate.
Figures and Tables -
Analysis 2.4

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 4 Ectopic pregnancy rate.

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 5 Miscarriage rate.
Figures and Tables -
Analysis 2.5

Comparison 2 Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube, Outcome 5 Miscarriage rate.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 1 Clinical pregnancy rate.
Figures and Tables -
Analysis 3.1

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 1 Clinical pregnancy rate.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 2 Biochemical pregnancy rate.
Figures and Tables -
Analysis 3.2

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 2 Biochemical pregnancy rate.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 3 Pregnancy rate ‐ any definition.
Figures and Tables -
Analysis 3.3

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 3 Pregnancy rate ‐ any definition.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 4 Ectopic pregnancy rate.
Figures and Tables -
Analysis 3.4

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 4 Ectopic pregnancy rate.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 5 Miscarriage rate.
Figures and Tables -
Analysis 3.5

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 5 Miscarriage rate.

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 6 Surgical complication rate.
Figures and Tables -
Analysis 3.6

Comparison 3 Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges, Outcome 6 Surgical complication rate.

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 1 Ongoing pregnancy rate.
Figures and Tables -
Analysis 4.1

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 1 Ongoing pregnancy rate.

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 2 Clinical pregnancy rate.
Figures and Tables -
Analysis 4.2

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 2 Clinical pregnancy rate.

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 3 Pregnancy rate ‐ any definition.
Figures and Tables -
Analysis 4.3

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 3 Pregnancy rate ‐ any definition.

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 4 Ectopic pregnancy rate.
Figures and Tables -
Analysis 4.4

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 4 Ectopic pregnancy rate.

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 5 Miscarriage rate.
Figures and Tables -
Analysis 4.5

Comparison 4 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 5 Miscarriage rate.

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 1 Salpingectomy (all methods) VERSUS no surgical treatment.
Figures and Tables -
Analysis 5.1

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 1 Salpingectomy (all methods) VERSUS no surgical treatment.

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 2 Tubal occlusion (all methods) VERSUS no surgical treatment.
Figures and Tables -
Analysis 5.2

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 2 Tubal occlusion (all methods) VERSUS no surgical treatment.

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 3 Aspiration of hydro salpingeal fluid (all methods) VERSUS no surgical treatment.
Figures and Tables -
Analysis 5.3

Comparison 5 Surgical treatment (all types) VERSUS no surgical treatment, Outcome 3 Aspiration of hydro salpingeal fluid (all methods) VERSUS no surgical treatment.

Comparison 6 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 1 Tubal occlusion (all methods) VERSUS Salpingectomy (all methods).
Figures and Tables -
Analysis 6.1

Comparison 6 Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube, Outcome 1 Tubal occlusion (all methods) VERSUS Salpingectomy (all methods).

Comparison 1. Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Ongoing pregnancy rate Show forest plot

3

329

Odds Ratio (M‐H, Fixed, 95% CI)

2.20 [1.26, 3.82]

1.1 Laparoscopic bilateral salpingectomy and adhesiolysis versus no surgery on the fallopian tube

1

60

Odds Ratio (M‐H, Fixed, 95% CI)

3.06 [0.97, 9.66]

1.2 Laparoscopic salpingectomy versus no intervention

2

269

Odds Ratio (M‐H, Fixed, 95% CI)

1.99 [1.06, 3.74]

2 Clinical pregnancy rate Show forest plot

3

395

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.31 [1.48, 3.62]

2.1 Laparoscopic salpingectomy versus no intervention

3

395

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.31 [1.48, 3.62]

3 Pregnancy rate ‐ any definition Show forest plot

4

455

Odds Ratio (M‐H, Fixed, 95% CI)

2.49 [1.60, 3.86]

3.1 Laparoscopic bilateral salpingectomy and adhesiolysis versus no surgery on the fallopian tube

1

60

Odds Ratio (M‐H, Fixed, 95% CI)

3.06 [0.97, 9.66]

3.2 Laparoscopic salpingectomy versus no intervention

3

395

Odds Ratio (M‐H, Fixed, 95% CI)

2.40 [1.49, 3.86]

4 Ectopic pregnancy rate Show forest plot

3

329

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.68 [0.13, 3.56]

4.1 Laparoscopic bilateral salpingectomy and adhesiolysis versus laparoscopic adhesiolysis

1

60

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.00, 6.82]

4.2 Laparoscopic salpingectomy versus no intervention

2

269

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.96 [0.15, 6.01]

5 Miscarriage rate Show forest plot

3

115

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.38 [0.11, 1.28]

5.1 Laparoscopic bilateral salpingectomy and adhesiolysis versus laparoscopic adhesiolysis

1

38

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.17 [0.01, 5.24]

5.2 Laparoscopic salpingectomy versus no intervention

2

77

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.42 [0.12, 1.57]

6 Surgical complication rate Show forest plot

1

204

Peto Odds Ratio (Peto, Fixed, 95% CI)

5.86 [0.35, 96.79]

6.1 Laparoscopic salpingectomy versus no intervention

1

204

Peto Odds Ratio (Peto, Fixed, 95% CI)

5.86 [0.35, 96.79]

Figures and Tables -
Comparison 1. Laparoscopic surgery on the fallopian tube (all types) VERSUS No surgery on the fallopian tube (all types)
Comparison 2. Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Ongoing pregnancy rate Show forest plot

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

7.21 [0.87, 59.57]

1.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

7.21 [0.87, 59.57]

2 Clinical pregnancy rate Show forest plot

2

209

Odds Ratio (M‐H, Fixed, 95% CI)

4.66 [2.17, 10.01]

2.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

4.33 [0.88, 21.30]

2.2 Proximal tubal clamping VERSUS no intervention

1

144

Odds Ratio (M‐H, Fixed, 95% CI)

4.78 [2.01, 11.38]

3 Pregnancy rate ‐ any definition Show forest plot

2

209

Odds Ratio (M‐H, Fixed, 95% CI)

4.66 [2.17, 10.01]

3.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

4.33 [0.88, 21.30]

3.2 Laparoscopic proximal tubal clamping VERSUS no intervention

1

144

Odds Ratio (M‐H, Fixed, 95% CI)

4.78 [2.01, 11.38]

4 Ectopic pregnancy rate Show forest plot

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

0.94 [0.04, 24.25]

4.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

0.94 [0.04, 24.25]

5 Miscarriage rate Show forest plot

1

25

Odds Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 3.09]

5.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS no intervention

1

25

Odds Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 3.09]

Figures and Tables -
Comparison 2. Occlusion of the fallopian tube VERSUS no intervention on the fallopian tube
Comparison 3. Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Clinical pregnancy rate Show forest plot

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

1.97 [0.62, 6.29]

1.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

1.97 [0.62, 6.29]

2 Biochemical pregnancy rate Show forest plot

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

2.78 [0.93, 8.27]

2.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

2.78 [0.93, 8.27]

3 Pregnancy rate ‐ any definition Show forest plot

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

1.97 [0.62, 6.29]

3.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

1.97 [0.62, 6.29]

4 Ectopic pregnancy rate Show forest plot

1

66

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

66

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5 Miscarriage rate Show forest plot

1

16

Odds Ratio (M‐H, Fixed, 95% CI)

1.25 [0.09, 17.65]

5.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

16

Odds Ratio (M‐H, Fixed, 95% CI)

1.25 [0.09, 17.65]

6 Surgical complication rate Show forest plot

1

66

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.1 Ultrasound guided aspiration of hydrosalpinges just after oocyte retrieval VERSUS no aspiration

1

66

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figures and Tables -
Comparison 3. Aspiration of the hydrosalpinges versus non aspiration of hydrosalpinges
Comparison 4. Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Ongoing pregnancy rate Show forest plot

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.65 [0.74, 3.71]

1.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.65 [0.74, 3.71]

2 Clinical pregnancy rate Show forest plot

2

238

Odds Ratio (M‐H, Fixed, 95% CI)

1.28 [0.76, 2.14]

2.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.63 [0.74, 3.59]

2.2 Laparoscopic proximal tubal clamping VERSUS laparoscopic salpingectomy

1

138

Odds Ratio (M‐H, Fixed, 95% CI)

1.06 [0.53, 2.12]

3 Pregnancy rate ‐ any definition Show forest plot

2

238

Odds Ratio (M‐H, Fixed, 95% CI)

1.28 [0.76, 2.14]

3.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.63 [0.74, 3.59]

3.2 Laparoscopic proximal tubal clamping VERSUS laparoscopic salpingectomy

1

138

Odds Ratio (M‐H, Fixed, 95% CI)

1.06 [0.53, 2.12]

4 Ectopic pregnancy rate Show forest plot

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

3.06 [0.12, 76.95]

4.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

3.06 [0.12, 76.95]

5 Miscarriage rate Show forest plot

1

43

Odds Ratio (M‐H, Fixed, 95% CI)

1.35 [0.20, 9.02]

5.1 Laparoscopic proximal tubal occlusion by diathermy VERSUS laparoscopic salpingectomy

1

43

Odds Ratio (M‐H, Fixed, 95% CI)

1.35 [0.20, 9.02]

Figures and Tables -
Comparison 4. Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube
Comparison 5. Surgical treatment (all types) VERSUS no surgical treatment

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Salpingectomy (all methods) VERSUS no surgical treatment Show forest plot

4

Odds Ratio (M‐H, Fixed, 95% CI)

Subtotals only

1.1 Ongoing pregnancy rate

3

329

Odds Ratio (M‐H, Fixed, 95% CI)

2.20 [1.26, 3.82]

1.2 Clinical pregnancy rate

3

395

Odds Ratio (M‐H, Fixed, 95% CI)

2.40 [1.49, 3.86]

1.3 Pregnancy rate ‐ any definition

4

455

Odds Ratio (M‐H, Fixed, 95% CI)

2.49 [1.60, 3.86]

1.4 Ectopic pregnancy rate

3

329

Odds Ratio (M‐H, Fixed, 95% CI)

0.64 [0.15, 2.75]

1.5 Miscarriage rate

3

329

Odds Ratio (M‐H, Fixed, 95% CI)

0.86 [0.31, 2.38]

1.6 Surgical complication rate

1

204

Odds Ratio (M‐H, Fixed, 95% CI)

3.86 [0.18, 81.52]

2 Tubal occlusion (all methods) VERSUS no surgical treatment Show forest plot

2

Odds Ratio (M‐H, Fixed, 95% CI)

Subtotals only

2.1 Ongoing pregnancy rate

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

7.21 [0.87, 59.57]

2.2 Clinical pregnancy rate

2

209

Odds Ratio (M‐H, Fixed, 95% CI)

4.66 [2.17, 10.01]

2.3 Ectopic pregnancy rate

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

0.94 [0.04, 24.25]

2.4 Miscarriage rate

1

65

Odds Ratio (M‐H, Fixed, 95% CI)

0.89 [0.09, 9.28]

3 Aspiration of hydro salpingeal fluid (all methods) VERSUS no surgical treatment Show forest plot

1

Odds Ratio (M‐H, Fixed, 95% CI)

Subtotals only

3.1 Clinical pregnancy rate

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

1.97 [0.62, 6.29]

3.2 Biochemical pregnancy rate

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

2.78 [0.93, 8.27]

3.3 Ectopic pregnancy rate

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.4 Miscarriage rate

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

2.07 [0.18, 24.01]

3.5 Surgical complication rate

1

64

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figures and Tables -
Comparison 5. Surgical treatment (all types) VERSUS no surgical treatment
Comparison 6. Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Tubal occlusion (all methods) VERSUS Salpingectomy (all methods) Show forest plot

2

Odds Ratio (M‐H, Fixed, 95% CI)

Subtotals only

1.1 Ongoing pregnancy rate

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.65 [0.74, 3.71]

1.2 Clinical pregnancy rate

2

238

Odds Ratio (M‐H, Fixed, 95% CI)

1.28 [0.76, 2.14]

1.3 Ectopic pregnancy rate

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

0.33 [0.01, 8.21]

1.4 Miscarriage rate

1

100

Odds Ratio (M‐H, Fixed, 95% CI)

1.53 [0.24, 9.59]

Figures and Tables -
Comparison 6. Laparoscopic surgery on the fallopian tube (all types) VERSUS (any other) laparoscopic surgery on the fallopian tube